Neogen Corporation (NEOG) - Stock Analysis
Last updated: Apr 26, 2026
Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Neogen shows improving operational execution with a stable revenue base, cost savings initiatives, and positive industry tailwinds. The stock exhibits positive technical momentum and analyst upgrades. Legal headwinds remain but ongoing margin expansion and upcoming earnings confer cautious near-term upside potential.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Liquidity Strength ⢠Cash Flow Rebound ⢠Profitability Gap NEOG shows improving near-term liquidity, cash flow, and leverage, but persistent losses and a heavy intangible-asset base keep the turnaround incomplete.
Price Behavior
Key Price Behavior Insights: ⢠Higher support base ⢠Near-term resistance ⢠Sharp volatility Support Level: $9.20-$9.30 Resistance Level: $9.60-$10.00 NEOG has improved over the last month with support holding around $9.20-$9.30, but repeated failure near $9.60-$10.00 keeps the short-term setup mixed and vulnerable to sharp pullbacks.
Sentiment & News
Key News Insights: ⢠Earnings Beat ⢠Margin Pressure ⢠Product Validation Neogen beat fiscal Q3 expectations and raised guidance, but the stock fell on margin pressure and animal safety weakness despite progress in food safety and product validation. #margin؜غءâ
AI Summary
NEOG is shifting from a simple turnaround bet to a more credible core-business stabilization story, with genomics divestiture, improving cash generation, and Food Safety strength offsetting the still-fragile recovery in Animal Safety, margin pressure, and recurring quality/execution risks that must be fixed before the stock can rerate.
Description
Neogen Corporation develops, manufactures and sells products used to detect, mitigate and monitor biological, chemical and sanitary hazards across the food and animal sectors. Its Food Safety business supplies diagnostic test kits and sanitation assays to food and feed producers, processors, grain handlers, dairies, laboratories and related manufacturers to identify pathogens, toxins, residues, allergens and other contaminants, while its Animal Safety business provides veterinary medicines, vaccines, diagnostic tools, disinfectants and genomics services, including drug-residue and toxicology testing for animals. The company was incorporated in 1981 and is headquartered in Lansing, Michigan.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Jan 1 | Jan 8 | NEOG | Neogen Corporation | Neogen shows improving operational execution with a stable revenue base, cost savings initiatives, and positive industry tailwinds. The stock exhibits positive technical momentum and analyst upgrades. Legal headwinds remain but ongoing margin expansion and upcoming earnings confer cautious near-term upside potential. | Closed | +38.9% |